Home › Asset managers › Franklin Templeton › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Franklin Templeton voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,065 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Franklin Templeton voted | Funds |
|---|---|---|---|---|---|---|---|
| CONCENTRADORA FIBRA DANHOS SA DE CV | March 31, 2025 | Ratify Salvador Daniel Kabbaz Zaga as Member of Technical Committee | Director Elections | Board | AGAINST | 2 | |
| CONTAINER CORPORATION OF INDIA LTD. | September 25, 2024 | Elect Prabhas Dansana as Part Time Government Director | Director Elections | Board | AGAINST | 2 | |
| CONTAINER CORPORATION OF INDIA LTD. | September 25, 2024 | Elect Priyaranjan Parhi as Director (International Marketing & Operations) | Director Elections | Board | AGAINST | 2 | |
| CONTAINER CORPORATION OF INDIA LTD. | September 25, 2024 | Elect Sandeep Jain as Part Time Government Director | Director Elections | Board | AGAINST | 2 | |
| CONTAINER CORPORATION OF INDIA LTD. | September 25, 2024 | Reelect Ajit Kumar Panda as Director | Director Elections | Board | AGAINST | 2 | |
| CONTAINER CORPORATION OF INDIA LTD. | September 25, 2024 | Reelect Mohammad Azhar Shams as Director | Director Elections | Board | AGAINST | 2 | |
| CONTEMPORARY AMPEREX TECHNOLOGY CO. LTD. | April 8, 2025 | Approve Estimated Amount of Guarantees | Capital Structure | Board | AGAINST | 2 | |
| CONTROLADORA ALPEK SAB DE CV | May 13, 2025 | Elect Directors and Chairs of Audit and Corporate Practices Committees; Fix Their Remuneration | Director Elections | Board | AGAINST | 2 | |
| COROMANDEL INTERNATIONAL LTD. | September 11, 2024 | Approve Payment of Remuneration to A. Vellayan as Chairman Emeritus, a Related Party for Holding the Office or Place of Profit | Compensation | Board | AGAINST | 2 | |
| COROMANDEL INTERNATIONAL LTD. | June 7, 2025 | Approve Appointment and Remuneration of Natarajan Srinivasan as Whole-Time Director, Designated as Executive Vice Chairman | Compensation | Board | AGAINST | 2 | |
| CORPORACION ACCIONA ENERGIAS RENOVABLES SA | June 5, 2025 | Advisory Vote on Remuneration Report | Compensation | Board | AGAINST | 2 | |
| CORTEVA INC. | April 30, 2025 | Advisory resolution to approve executive compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| COSMO AM&T CO. LTD. | March 24, 2025 | Elect Hong Dong-hwan as Inside Director | Director Elections | Board | AGAINST | 2 | |
| COSMOS PHARMACEUTICAL CORP. | August 20, 2024 | Appoint Grant Thornton Taiyo LLC as New External Audit Firm | Audit-related | Board | AGAINST | 2 | |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | July 9, 2024 | Adopt 2024 Share Option Scheme and Related Transactions | Compensation | Board | AGAINST | 2 | |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | July 9, 2024 | Approve Scheme Mandate Limit and Related Transactions | Compensation | Board | AGAINST | 2 | |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | July 9, 2024 | Approve Service Provider Sublimit and Related Transactions | Compensation | Board | AGAINST | 2 | |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | May 23, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | May 23, 2025 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| COUPANG INC. | June 12, 2025 | Election of Directors: Kevin Warsh | Director Elections | Board | AGAINST | 2 | |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Arrangement of Guarantees | Capital Structure | Board | AGAINST | 2 | |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Issuance of Debt Financing Instruments | Capital Structure | Board | AGAINST | 2 | |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights for Additional A Shares and H Shares | Capital Structure | Board | AGAINST | 2 | |
| CSG HOLDING CO. LTD. | June 24, 2025 | Approve Asset Pool Business | Capital Structure | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds | Capital Structure | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds | Capital Structure | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | April 15, 2025 | Approve Use of Idle Raised Funds and Own Funds for Cash Management | Extraordinary Transactions | Board | AGAINST | 2 | |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends | Capital Structure | Board | AGAINST | 2 | |
| D'IETEREN GROUP | June 5, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 2 | |
| D'IETEREN GROUP | June 5, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director Ishiguro, Takeshi | Director Elections | Board | AGAINST | 2 | |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director Shimizu, Tetsuya | Director Elections | Board | AGAINST | 2 | |
| DALMIA BHARAT LTD. | June 30, 2025 | Reelect Yadu Hari Dalmia as Director | Director Elections | Board | AGAINST | 2 | |
| DARDEN RESTAURANTS INC. | September 18, 2024 | To vote on a shareholder proposal requesting the Company comply with WHO guidelines for antimicrobials for food-producing animals in the supply chain if properly presented at the meeting. | Environment or Climate | Shareholder | Against | FOR | 2 |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | December 31, 2024 | Approve Financing Proposal of Datang International as the Parent Company for the Year of 2025 | Capital Structure | Board | AGAINST | 2 | |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | March 25, 2025 | Approve Centralized Registration of Non-Financial Corporate Debt Financing Instruments and Shelf Offering of Corporate Bonds | Capital Structure | Board | AGAINST | 2 | |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 2 | |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Authorize Board to Repurchase Shares | Capital Structure | Board | AGAINST | 2 | |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Grant Board Authority to Issue Shares and Exclude Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Alessandra Garavoglia as Non-Executive Director | Director Elections | Board | AGAINST | 2 | |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Luca Garavoglia as Non-Executive Director | Director Elections | Board | AGAINST | 2 | |
| DEMANT A/S | March 6, 2025 | Approve Remuneration Report (Advisory Vote) | Compensation | Board | AGAINST | 2 | |
| DEMANT A/S | March 6, 2025 | Reelect Niels B. Christiansen as Director | Director Elections | Board | ABSTAIN | 2 | |
| DEMANT A/S | March 6, 2025 | Reelect Niels Jacobsen as Director | Director Elections | Board | ABSTAIN | 2 | |
| DENKA CO. LTD. | June 20, 2025 | Elect Director Imai, Toshio | Director Elections | Board | AGAINST | 2 | |
| DENKA CO. LTD. | June 20, 2025 | Elect Director Ishida, Ikuo | Director Elections | Board | AGAINST | 2 | |
| DENKA CO. LTD. | June 20, 2025 | Elect Director and Audit Committee Member Yamamoto, Akio | Director Elections | Board | AGAINST | 2 | |
| DENTSU SOKEN INC. | March 24, 2025 | Elect Director and Audit Committee Member Sekiguchi, Atsuhiro | Director Elections | Board | AGAINST | 2 | |
| DEXCO SA | July 24, 2024 | Elect Harry Schmelzer Junior as Director | Director Elections | Board | AGAINST | 2 | |
| DEXUS | October 30, 2024 | Approve Conditional Spill Resolution | Compensation | Board | AGAINST | 2 | |
| DEXUS | October 30, 2024 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| DFI RETAIL GROUP HOLDINGS LTD. | May 2, 2025 | Elect Graham Baker as Director | Director Elections | Board | AGAINST | 2 | |
| DGB FINANCIAL GROUP CO. LTD. | March 26, 2025 | Elect Cho Dong-hwan as Outside Director to Serve as an Audit Committee Member | Director Elections | Board | AGAINST | 2 | |
| DGB FINANCIAL GROUP CO. LTD. | March 26, 2025 | Elect Cho Gang-rae as Outside Director | Director Elections | Board | AGAINST | 2 | |
| DGB FINANCIAL GROUP CO. LTD. | March 26, 2025 | Elect Jeong Jae-su as Outside Director | Director Elections | Board | AGAINST | 2 | |
| DGB FINANCIAL GROUP CO. LTD. | March 26, 2025 | Elect Noh Tae-sik as Outside Director | Director Elections | Board | AGAINST | 2 | |
| DIASORIN SPA | April 28, 2025 | Approve Long-Term Incentive Plan | Compensation | Board | AGAINST | 2 | |
| DIASORIN SPA | April 28, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 2 | |
| DIASORIN SPA | April 28, 2025 | Approve Stock Option Plan | Compensation | Board | AGAINST | 2 | |
| DIC CORP. | March 27, 2025 | Elect Director Ino, Kaoru | Director Elections | Board | AGAINST | 2 | |
| DIPLOMA PLC | January 15, 2025 | Re-elect David Lowden as Director | Director Elections | Board | AGAINST | 2 | |
| DIVI'S LABORATORIES LTD. | August 12, 2024 | Approve Reappointment and Remuneration of Murali K. Divi as Managing Director | Compensation | Board | AGAINST | 2 | |
| DIVI'S LABORATORIES LTD. | August 12, 2024 | Approve Reappointment and Remuneration of N.V. Ramana as Executive Director | Compensation | Board | AGAINST | 2 | |
| DIXON TECHNOLOGIES (INDIA) LTD. | September 25, 2024 | Approve Enhancement of the Limits of Inter-corporate Loans, Investments, Guarantee or Security and Acquisition | Capital Structure | Board | AGAINST | 2 | |
| DKSH HOLDING LTD. | March 27, 2025 | Reappoint Eunice Zehnder-Lai as Member of the Nomination and Compensation Committee | Director Elections | Board | AGAINST | 2 | |
| DKSH HOLDING LTD. | March 27, 2025 | Reelect Eunice Zehnder-Lai as Director | Director Elections | Board | AGAINST | 2 | |
| DLF LTD. | August 7, 2024 | Reelect Anushka Singh as Director | Director Elections | Board | AGAINST | 2 |
← Previous Page 20 of 61 Next →
← Back to Franklin Templeton 2024-2025 overview
Built October 13, 2026 from SEC Form N-PX filings.